Tarsus Pharmaceuticals Inc (TARS) — Cash Flow Reinvestment Rate
Tarsus Pharmaceuticals Inc (TARS) has a Cash Flow Reinvestment Rate of 3.21x as of December 2025, reinvesting $61.99 Million (capex $6.36 Million plus investments $55.63 Million) from operating cash flow of $19.33 Million. Explore TARS capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Tarsus Pharmaceuticals Inc Cash Flow Reinvestment Rate (2021–2021)
Historical reinvestment intensity for Tarsus Pharmaceuticals Inc across 1 annual periods. Also explore Tarsus Pharmaceuticals Inc (TARS) total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Tarsus Pharmaceuticals Inc (2021–2021)
Year-by-year capital reinvestment analysis for Tarsus Pharmaceuticals Inc. For live market cap and broader valuation context, see TARS company net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2021 | 0.31x | $1.17 Million | $3.75 Million | $586.00K | — |